Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2791 AL 2805

Sphingolipids in Alzheimer's disease, how can we target them?

Crivelli SM, Giovagnoni C, Visseren L, Scheithauer AL, de Wit N, den Hoedt S, Losen M, Mulder MT, Walter J, de Vries HE, Bieberich E, Martinez-Martinez P.

Adv Drug Deliv Rev. 2020;159:214-231. doi: 10.1016/j.addr.2019.12.003. Epub 2020 Jan 3.

The Effects of Probiotics and Prebiotics on Mental Disorders: A Review on Depression, Anxiety, Alzheimer, and Autism Spectrum Disorders

Ansari F, Pourjafar H, Tabrizi A, Homayouni A.

Curr Pharm Biotechnol. 2020;21(7):555-565. doi: 10.2174/1389201021666200107113812.

Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer's disease

Akel H, Ismail R, Csóka I.

Eur J Pharm Biopharm. 2020 Mar;148:38-53. doi: 10.1016/j.ejpb.2019.12.014. Epub 2020 Jan 8.

The efficacy of statins in the treatment of Alzheimer's disease: a meta-analysis of randomized controlled trial

Xuan K, Zhao T, Qu G, Liu H, Chen X, Sun Y.

Neurol Sci. 2020 Jun;41(6):1391-1404. doi: 10.1007/s10072-020-04243-6. Epub 2020 Jan 13.

Quercetin in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies

Zhang XW, Chen JY, Ouyang D, Lu JH.

Int J Mol Sci. 2020 Jan 13;21(2):493. doi: 10.3390/ijms21020493.

Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease

Chatterjee P, Fernando M, Fernando B, Dias CB, Shah T, Silva R, Williams S, Pedrini S, Hillebrandt H, Goozee K, Barin E, Sohrabi HR, Garg M, Cunnane S, Martins RN.

Mech Ageing Dev. 2020 Mar;186:111209. doi: 10.1016/j.mad.2020.111209. Epub 2020 Jan 15.

Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data

Conrado DJ, Duvvuri S, Geerts H, Burton J, Biesdorf C, Ahamadi M, Macha S, Hather G, Francisco Morales J, Podichetty J, Nicholas T, Stephenson D, Trame M, Romero K, Corrigan B; Drug Development Tools in the Alzheimer Disease Continuum (DDT-AD) Working Group.

Clin Pharmacol Ther. 2020 Apr;107(4):796-805. doi: 10.1002/cpt.1782. Epub 2020 Mar 11.

Alzheimer's disease: review of current nanotechnological therapeutic strategies

Baranowska-Wójcik E, Szwajgier D.

Expert Rev Neurother. 2020 Mar;20(3):271-279. doi: 10.1080/14737175.2020.1719069. Epub 2020 Jan 27.

Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease

Yoshida K, Moein A, Bittner T, Ostrowitzki S, Lin H, Honigberg L, Jin JY, Quartino A.

Alzheimers Res Ther. 2020 Jan 22;12(1):16. doi: 10.1186/s13195-020-0580-2.

Neuroinflammation and Neurogenesis in Alzheimer's Disease and Potential Therapeutic Approaches

Sung PS, Lin PY, Liu CH, Su HC, Tsai KJ.

Int J Mol Sci. 2020 Jan 21;21(3):701. doi: 10.3390/ijms21030701.

Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer's Therapeutics

Mouchlis VD, Melagraki G, Zacharia LC, Afantitis A.

Int J Mol Sci. 2020 Jan 21;21(3):703. doi: 10.3390/ijms21030703.

An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease

Haake A, Nguyen K, Friedman L, Chakkamparambil B, Grossberg GT.

Expert Opin Drug Saf. 2020 Feb;19(2):147-157. doi: 10.1080/14740338.2020.1721456. Epub 2020 Jan 28.

Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease

Zuccarello E, Acquarone E, Calcagno E, Argyrousi EK, Deng SX, Landry DW, Arancio O, Fiorito J.

Biochem Pharmacol. 2020 Jun;176:113818. doi: 10.1016/j.bcp.2020.113818. Epub 2020 Jan 21.

Crosstalk between the M(1) muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?

Thompson KJ, Tobin AB.

Cell Signal. 2020 Jun;70:109545. doi: 10.1016/j.cellsig.2020.109545. Epub 2020 Jan 21.

"Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease

Rao CV, Asch AS, Carr DJJ, Yamada HY.

Aging Cell. 2020 Mar;19(3):e13109. doi: 10.1111/acel.13109. Epub 2020 Jan 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias